Calumet Specialty Products Partners (NASDAQ:CLMT) Upgraded at UBS Group

UBS Group upgraded shares of Calumet Specialty Products Partners (NASDAQ:CLMT) from a sell rating to a neutral rating in a report released on Monday morning, Marketbeat reports. They currently have $12.00 price objective on the oil and gas company’s stock, down from their prior price objective of $15.00.

A number of other analysts also recently weighed in on the stock. TD Cowen downgraded shares of Calumet Specialty Products Partners from a “buy” rating to a “hold” rating and reduced their target price for the stock from $26.00 to $16.00 in a research report on Tuesday, March 4th. HC Wainwright reaffirmed a “buy” rating and issued a $33.00 target price on shares of Calumet Specialty Products Partners in a research report on Monday, March 3rd. Wells Fargo & Company reduced their target price on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 5th. Finally, StockNews.com raised shares of Calumet Specialty Products Partners to a “sell” rating in a research report on Monday, November 18th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $20.80.

Calumet Specialty Products Partners Trading Up 9.4 %

Shares of Calumet Specialty Products Partners stock opened at $13.19 on Monday. The company’s fifty day simple moving average is $16.05 and its two-hundred day simple moving average is $18.76. The company has a market cap of $1.13 billion, a P/E ratio of -4.78 and a beta of 1.88. Calumet Specialty Products Partners has a 12-month low of $9.97 and a 12-month high of $25.29.

Calumet Specialty Products Partners (NASDAQ:CLMT) last issued its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to analysts’ expectations of $921.76 million. The firm’s revenue for the quarter was down 2.8% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.59) earnings per share. Analysts predict that Calumet Specialty Products Partners will post -3.02 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO David Lunin bought 2,500 shares of the stock in a transaction on Tuesday, March 4th. The shares were acquired at an average price of $13.05 per share, for a total transaction of $32,625.00. Following the purchase, the chief financial officer now owns 2,500 shares of the company’s stock, valued at approximately $32,625. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jennifer Straumins sold 37,861 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $21.42, for a total transaction of $810,982.62. Following the transaction, the director now owns 1,184,589 shares in the company, valued at $25,373,896.38. This represents a 3.10 % decrease in their position. The disclosure for this sale can be found here. 2.91% of the stock is currently owned by company insiders.

Calumet Specialty Products Partners Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.